BMC Medicine is a prestigious, peer-reviewed journal published by BMC, specializing in the rapidly evolving field of medicine. Launched in 2003, this journal has consistently operated under an Open Access model, ensuring that groundbreaking research is freely accessible to the global community. With an impressive impact factor, BMC Medicine holds a distinguished Q1 ranking in the field of Medicine (miscellaneous) and ranks #29 out of 636 in General Medicine according to Scopus, placing it in the top 95th percentile of its category. This journal is dedicated to disseminating high-quality research that advances the understanding and practice of medicine, with a comprehensive focus that includes clinical research, public health, and health policy. As part of its commitment to fostering innovation and collaboration in healthcare, BMC Medicine invites researchers, professionals, and students to contribute to this vital platform that addresses the most pressing medical challenges of our time.

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

Yale Journal of Biology and Medicine, established in 1945, is a distinguished peer-reviewed academic journal published by Yale J Biology Medicine, Inc. This journal serves as an essential platform for the dissemination of high-quality research in the fields of biochemistry, genetics, molecular biology, and medicine. With a notable impact factor and ranking in the top quartiles (Q2) of both biochemistry and medicine categories according to the latest metrics, it underscores its relevance and influence in the academic community. Committed to advancing understanding in these dynamic fields, the journal encourages submissions that contribute to both fundamental and applied scientific knowledge. Although it does not currently follow an open access model, the journal remains highly accessible through various academic databases. Researchers, professionals, and students are invited to explore cutting-edge findings and innovative perspectives that continue to shape the landscape of biology and medicine.

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

The Journal of Biological Research-Bollettino della Societa Italiana di Biologia Sperimentale is a premier peer-reviewed journal published by PAGEPRESS PUBL, focusing on a diverse array of topics within the broad field of biological research. Established as an Open Access journal since 2009, it facilitates the dissemination of scientific knowledge across the globe, enhancing visibility and accessibility for researchers, professionals, and students alike. With an ISSN of 1826-8838 and E-ISSN 2284-0230, this journal serves as a platform for innovative studies in Biochemistry, Genetics, and Molecular Biology, with a growing emphasis on Plant Science. Although currently categorized in the Q4 quartile for various sub-disciplines, the journal is dedicated to fostering interdisciplinary collaboration and advancing research quality. The latest Scopus rankings indicate a burgeoning presence in the academic community, positioning itself at significant ranks within the fields it covers. With publication coverage extending from 2011 to 2024, the journal aims to push the frontiers of biological research while adapting to the evolving demands of the scientific community.

Nature Protocols, published by NATURE PORTFOLIO, is a premier academic journal specializing in the dissemination of innovative and practical experimental methodologies in the vast field of biochemistry, genetics, and molecular biology. With an impressive Scopus rank of #5 out of 221 journals and a 97th percentile status, it stands firmly in the Q1 quartile, reflecting its integral role in advancing scientific knowledge. Established in 2006, this journal provides an invaluable resource for researchers and practitioners aiming to refine their experimental techniques, ultimately driving forward the frontiers of life sciences. While currently operating under a subscription model, the journal continues to be a pivotal platform for sharing high-quality, peer-reviewed protocols that facilitate reproducibility and transparency in research. Addressing a global audience from its base in the United Kingdom, Nature Protocols is dedicated to fostering collaboration and innovation, making it indispensable for professionals and students engaged in cutting-edge scientific endeavors.

Advanced Biomedical Research, published by Wolters Kluwer Medknow Publications, is a prominent open access journal dedicated to advancing the field of biomedical research since its inception in 2012. With an ISSN of 2277-9175, this journal serves as a vital platform for researchers, professionals, and students to disseminate high-quality research findings and innovative ideas in a variety of topics within biochemistry, genetics, and molecular biology. Recognized within the Q3 category of the 2023 journal quartile rankings, it ranks 365th among general medicine journals and 187th in the general fields of biochemistry and genetics, underscoring its commitment to fostering scientific dialogue and collaboration. With its open access model, Advanced Biomedical Research ensures that research is readily accessible to a global audience, thereby enhancing the visibility and impact of scholarly work. As the journal continues to evolve through its converged editorial focus from 2019 to 2024, it aims to play a critical role in shaping the future of biomedical sciences in India and beyond.

Biochemia Medica is a premier open-access journal that has been at the forefront of advancing knowledge in the fields of medical biochemistry and laboratory medicine since its inception in 2006. Published by the Croatian Society of Medical Biochemistry & Laboratory Medicine, this journal serves a vital role in disseminating high-quality research findings and reviews that contribute to the understanding of biochemical processes in health and disease. With an impressive performance in the Scopus ranking, it holds a Q2 quartile category in both medical biochemistry and clinical biochemistry for 2023, reflecting its commitment to scholarly excellence and relevance in the field. As an open-access journal, Biochemia Medica ensures that research is freely accessible, fostering collaboration and innovation among researchers, healthcare professionals, and students globally. Positioned within a rapidly evolving scientific landscape, this journal is dedicated to bridging the gap between laboratory research and clinical application, making it an indispensable resource for anyone interested in the intersections of biochemistry and medicine.